EBD GmbH is part of the Knowledge & Networking Division of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
 
BIO-Europe 2015 BIO EBD Group
Share/Follow Us
Share this:
Follow this event:
Follow us on Twitter
Subscribe to our newsletters:

BIO-Europe® 2015 Press Releases

July 29, 2015European Technology Platform for Nanomedicine and ENATRANS European Consortium Launch the 2nd edition of the Nanomedicine Award The European Technology Platform for Nanomedicine (ETPN) and the EU-funded consortium, ENATRANS, have launched the second edition of the Nanomedicine Award to honor the best international nanomedicine innovations for 2015. The goal of the Award is to promote and reward...  more ►

July 7, 2015BIO-Europe® 2015 in Munich to take place November 2–4, 2015
Event expected to bring over 3,300 life science dealmakers to Bavaria
The twenty-first annual BIO-Europe® international life science partnering conference will be held in Munich, Germany, November 2–4, 2015. Organized by EBD Group, the event is co-hosted by BioM Biotech Cluster Development, the Bavarian Ministry of Economic Affairs and Media, Energy and Technology, and Cluster Biotechnology Bavaria. Bavaria is an ideal location because it ...  more ►

April 17, 2015Spotlight on Munich Business Facts Munich is home to a broad spectrum of high-capacity industries including life sciences; information and communication technology; automotive; aerospace; financial services; cross-industry technologies; skilled crafts; media/creative industries and corporate services. Munich is a growing city. The City of Munich has 1.46 million inhabitants (2013) and expects to grow to 1.65 ...  more ►



partnering360:Insight Latest headlines from partnering360:Insight

August 29, 2015 HSCI fosters broad collaboration At the Harvard Stem Cell Institute (HSCI), "Partnering is important at all levels," emphasized Brock Reeve, executive director. That impetus is important not just in the sciences, but also among foundations, large and small companies and investors throughout the life sciences community. more ►

August 29, 2015 RA Capital: Flexibility builds innovation Flexibility is the watchword for investment at RA Capital Management. As Peter Kolchinsky, managing director, explained, "Investors should be as flexible as possible. Therefore, we're a crossover fund manager. We invest in biotechnology companies whether they are public or private companies and, increasingly, are putting our efforts into company formation." more ►

August 8, 2015 Johnson & Johnson Innovation aims for disruption Johnson & Johnson Innovation, Boston, has high expectations for itself and its partners. "We're looking for ideas that will make a tremendous difference in patients' lives, not merely incremental progress," said Robert G. Urban, PhD, head of Johnson & Johnson Innovation, Boston. To do that, "we take advantage of the deep science emerging around us to develop bold platforms that make a big difference. more ►

July 21, 2015 Patient-centric Baxalta capitalizes on Cambridge When Baxalta Incorporated spun out of Baxter on July 1, it already qualified as "big pharma." With USD 6 billion in annual revenues, 16,000 employees, operations in 100 countries and USD 600 million invested in R&D, it focuses its assets tightly on the patient experience and expects its partners to do the same. more ►

June 12, 2015 Boehringer Ingelheim Pharmaceuticals: “The world is our laboratory” At Boehringer Ingelheim, “innovation is the element that defines us,” said Paola Casarosa, PhD, Corporate VP, Business Development and Licensing (BD&L)/Prescription Medicines. Its track record bears that out. Boehringer Ingelheim has a 125-year history of innovation that is based not only on its own discoveries but also upon novel finds from partners throughout the life sciences. more ►



Arrow Up


 
 

Follow this event: Follow us on Twitter
Sign up now
For news and updates

Privacy Policy and Cookies Terms of Use

See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2015 EBD GmbH
Privacy Policy and Cookies
Terms of Use